Murray KJ - Search Results

1

Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription.

Coghlan MP, Culbert AA, Cross DA, Corcoran SL, Yates JW, Pearce NJ, Rausch OL, Murphy GJ, Carter PS, Roxbee Cox L, Mills D, Brown MJ, Haigh D, Ward RW, Smith DG, Murray KJ, Reith AD, Holder JC. Coghlan MP, et al. Among authors: murray kj. Chem Biol. 2000 Oct;7(10):793-803. doi: 10.1016/s1074-5521(00)00025-9. Chem Biol. 2000. PMID: 11033082

2

Inhibition of cyclic nucleotide phosphodiesterase by derivatives of 1,3-bis(cyclopropylmethyl)xanthine.

Buckle DR, Arch JR, Connolly BJ, Fenwick AE, Foster KA, Murray KJ, Readshaw SA, Smallridge M, Smith DG. Buckle DR, et al. Among authors: murray kj. J Med Chem. 1994 Feb 18;37(4):476-85. doi: 10.1021/jm00030a007. J Med Chem. 1994. PMID: 8120866

3

A 5-HT4-like receptor in human right atrium.

Kaumann AJ, Sanders L, Brown AM, Murray KJ, Brown MJ. Kaumann AJ, et al. Among authors: murray kj. Naunyn Schmiedebergs Arch Pharmacol. 1991 Aug;344(2):150-9. doi: 10.1007/BF00167212. Naunyn Schmiedebergs Arch Pharmacol. 1991. PMID: 1658664

4

A 5-hydroxytryptamine receptor in human atrium.

Kaumann AJ, Sanders L, Brown AM, Murray KJ, Brown MJ. Kaumann AJ, et al. Among authors: murray kj. Br J Pharmacol. 1990 Aug;100(4):879-85. doi: 10.1111/j.1476-5381.1990.tb14108.x. Br J Pharmacol. 1990. PMID: 2169944 Free PMC article.

5

Cyclic AMP-dependent protein kinase activity ratio assay.

Murray KJ. Murray KJ. Methods Mol Biol. 1995;41:113-22. doi: 10.1385/0-89603-298-1:113. Methods Mol Biol. 1995. PMID: 7655549 No abstract available.

6

A comparison of the effects of adrenaline and noradrenaline on human heart: the role of beta 1- and beta 2-adrenoceptors in the stimulation of adenylate cyclase and contractile force.

Kaumann AJ, Hall JA, Murray KJ, Wells FC, Brown MJ. Kaumann AJ, et al. Among authors: murray kj. Eur Heart J. 1989 Jun;10 Suppl B:29-37. doi: 10.1093/eurheartj/10.suppl_b.29. Eur Heart J. 1989. PMID: 2572419

7

Potential use of selective phosphodiesterase inhibitors in the treatment of asthma.

Murray KJ, Eden RJ, England PJ, Dolan J, Grimsditch DC, Stutchbury CA, Patel B, Reeves ML, Worby A, Torphy TJ, et al. Murray KJ, et al. Agents Actions Suppl. 1991;34:27-46. Agents Actions Suppl. 1991. PMID: 1665307

8

Use of a synthetic dodecapeptide (malantide) to measure the cyclic AMP-dependent protein kinase activity ratio in a variety of tissues.

Murray KJ, England PJ, Lynham JA, Mills D, Schmitz-Peiffer C, Reeves ML. Murray KJ, et al. Biochem J. 1990 May 1;267(3):703-8. doi: 10.1042/bj2670703. Biochem J. 1990. PMID: 2160235 Free PMC article.

9

8-(4-Chlorophenyl)thio-cyclic AMP is a potent inhibitor of the cyclic GMP-specific phosphodiesterase (PDE VA).

Connolly BJ, Willits PB, Warrington BH, Murray KJ. Connolly BJ, et al. Among authors: murray kj. Biochem Pharmacol. 1992 Dec 15;44(12):2303-6. doi: 10.1016/0006-2952(92)90673-7. Biochem Pharmacol. 1992. PMID: 1335252

10

Inhibitors of cyclic nucleotide phosphodiesterases as therapeutic agents.

Murray KJ, England PJ. Murray KJ, et al. Biochem Soc Trans. 1992 May;20(2):460-4. doi: 10.1042/bst0200460. Biochem Soc Trans. 1992. PMID: 1327922 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

175 results

Search Page

Filters